We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Centers for Medicare & Medicaid Services made waves this week by authorizing Medicare Part B plans to implement step therapy for new patients and negotiate prices with drugmakers in an effort to control pharmaceutical costs.